ES2142388T3 - Agente anti-diabetico. - Google Patents

Agente anti-diabetico.

Info

Publication number
ES2142388T3
ES2142388T3 ES94400767T ES94400767T ES2142388T3 ES 2142388 T3 ES2142388 T3 ES 2142388T3 ES 94400767 T ES94400767 T ES 94400767T ES 94400767 T ES94400767 T ES 94400767T ES 2142388 T3 ES2142388 T3 ES 2142388T3
Authority
ES
Spain
Prior art keywords
antidiabetic agent
antidiabetic
carbon
diabetic agent
spherical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94400767T
Other languages
English (en)
Inventor
Michihito Ise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Application granted granted Critical
Publication of ES2142388T3 publication Critical patent/ES2142388T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN AGENTE ANTIDIABETICO CONTIENE UN CARBONO ESFERICO (POR EJEMPLO, UN CARBONO ESFERICO ACTIVADO O UN ABSORBENTE CARBONACEO ESFERICO) COMO UN INGREDIENTE ACTIVO. EL AGENTE ANTIDIABETICO PUEDE SER USADO PARA TRATAR DIABETES, PREFERIBLEMENTE POR ADMINISTRACION ORAL Y NO PUEDE SER DOLOROSO PARA UN PACIENTE CONVENCIONAL EN OPOSICION A LAS INYECCIONES DE INSULINA. ANTIDIABETICOS DISTINTOS A LOS CONVENCIONALES, EL AGENTE ANTIDIABETICO NO PUEDE INDUCIR HIPOGLUCEMIA.
ES94400767T 1993-04-14 1994-04-08 Agente anti-diabetico. Expired - Lifetime ES2142388T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11088293A JP3338119B2 (ja) 1993-04-14 1993-04-14 抗糖尿病剤

Publications (1)

Publication Number Publication Date
ES2142388T3 true ES2142388T3 (es) 2000-04-16

Family

ID=14547089

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94400767T Expired - Lifetime ES2142388T3 (es) 1993-04-14 1994-04-08 Agente anti-diabetico.

Country Status (9)

Country Link
US (1) US5380526A (es)
EP (1) EP0620006B1 (es)
JP (1) JP3338119B2 (es)
CN (1) CN1070705C (es)
AU (1) AU658338B2 (es)
CA (1) CA2113856C (es)
DE (1) DE69421839T2 (es)
ES (1) ES2142388T3 (es)
PH (1) PH30179A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855613A (en) * 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
IT1276130B1 (it) 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
CN1615908B (zh) * 2003-10-22 2011-09-28 株式会社吴羽 口服给药用吸附剂、以及肾病治疗或预防剂、和肝病治疗或预防剂
JPWO2005060980A1 (ja) * 2003-12-24 2007-12-13 正彬 少名子 疾患治療用医薬及び糖尿病治療用医薬
JPWO2005117920A1 (ja) * 2004-06-02 2008-04-03 株式会社クレハ 循環器機能障害因子除去剤
TW200626163A (en) * 2004-09-22 2006-08-01 Kureha Corp Agent for treating or preventing diabetic neuropathy
WO2006123618A1 (ja) * 2005-05-16 2006-11-23 Kureha Corporation 酸化ストレス抑制剤
US8247072B2 (en) 2006-02-14 2012-08-21 Eastman Chemical Company Resol beads, methods of making them and methods of using them
US20070207917A1 (en) * 2006-02-14 2007-09-06 Chester Wayne Sink Activated carbon monoliths and methods of making them
US20070191571A1 (en) * 2006-02-14 2007-08-16 Sink Chester W Resol beads, methods of making them, and methods of using them
US20070191572A1 (en) * 2006-02-14 2007-08-16 Tustin Gerald C Resol beads, methods of making them, and methods of using them
JP2007182448A (ja) * 2007-02-26 2007-07-19 Kureha Corp 血管性病変の治療又は予防剤
US20110017310A1 (en) 2007-07-02 2011-01-27 Parker Hannifin Ab Fluid valve arrangement
ES2586135T3 (es) * 2010-02-23 2016-10-11 Da Volterra Formulaciones para el suministro oral de adsorbentes en el intestino

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761284A (en) * 1977-12-27 1988-08-02 Kureha Kagaku Kogy Kabushiki Kaisha Antidote including activated carbon particles
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent

Also Published As

Publication number Publication date
AU658338B2 (en) 1995-04-06
CA2113856A1 (en) 1994-10-15
EP0620006B1 (en) 1999-12-01
JPH06298653A (ja) 1994-10-25
CN1070705C (zh) 2001-09-12
EP0620006A3 (en) 1995-02-01
PH30179A (en) 1997-01-21
DE69421839D1 (de) 2000-01-05
DE69421839T2 (de) 2000-05-25
AU5509294A (en) 1994-10-27
EP0620006A2 (en) 1994-10-19
US5380526A (en) 1995-01-10
CA2113856C (en) 1998-05-26
CN1101262A (zh) 1995-04-12
JP3338119B2 (ja) 2002-10-28

Similar Documents

Publication Publication Date Title
ES2142388T3 (es) Agente anti-diabetico.
AR012998A1 (es) Uso de un sensibilizador a insulina y de un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprende dichosensibilizador y dicho agente.
PE19496A1 (es) Formulacion de analogo de insulina humana
UY26425A1 (es) Formulación y método antidiabético
CA2105502A1 (fr) Composition apte a stimuler la secretion d'insuline destinee au traitement du diabete non insulino-dependant
AR018286A1 (es) Composicion farmaceutica que en calidad de principio activo contiene la asociacion de metformina y fibrato, y la utilizacion de esta asociacion para preparar medicamentos
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
TR200002134T2 (tr) Stabilize edilmiş teriparatid çözeltiler
UY25799A1 (es) Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina y otro agente antidiabético.
BR0112356A (pt) Formulações farmacêuticas tópicas e métodos de tratamento
UY24893A1 (es) Combinaciones para diabetes de sulfonilurea glitazona
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
Centers for Disease Control and Prevention (CDC Approaches to improving adherence to antituberculosis therapy--South Carolina and New York, 1986-1991
BR9810445A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e diguanida
KR950703353A (ko) 인슐린-의존적 진성 당뇨병을 예방 또는 치료하기 위한 인터루킨-10의 용도(Use of IL-10 to prevent or treat insulin-dependent diabetes mellitus)
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
WO2002053090A3 (fr) Association medicamenteuse d'une biguanine (metformine) et d'arginine
KR890004690A (ko) 당뇨병의 치료를 위한 베자피브레이드의 용도
EP0484112A3 (en) Use of lithium in the treatment or prophylaxis of molluscum contagiosum
DK1621207T3 (da) Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors
NO985571L (no) Legemiddel for autoimmunsykdommer
KR940005283A (ko) 활성 성분으로 글리센틴을 함유하는 약제
GR3032224T3 (en) Therapeutic agent for threatened abortion.
AR013352A1 (es) Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica.
MY138246A (en) Treatment of diabetes with thiazolidione and sulphonylurea.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 620006

Country of ref document: ES